Table 2

Baseline demographics for participants

Baseline demographics, n (%) unless specified otherwiseStandardised (n=20)Individualised (n=20)
Age, mean (SD)28.5 (6.0)30.4 (6.6)
Years since diagnosis, mean (SD)7.1 (4.8)9.3 (6.7)
Menstrual presentation
 Oligomenorrhoea15 (75)17 (85)
 Amenorrhoea5 (25)3 (15)
Current conventional medication use
 Yes1 (5)2 (10)
 No19 (95)18 (90)
  Of which previously used conventional medication*16 (80)11 (55)
Prior use of
 CAM: yes14 (70)16 (80)
 Acupuncture or CHM: yes8 (40)12 (60)
Parity ≥1
 Yes4 (20)1 (5)
 No16 (80)19 (95)
Ethnicity
 White British7 (35)9 (45)
 White: Irish and other white3 (15)6 (30)
 Mixed3 (15)1 (5)
 Asian: Indian, Pakistani, Bangladeshi and other Asian2 (10)0
 Black Caribbean and Black African2 (10)2 (10)
 Chinese1 (5)0
 Other/prefer not to answer2 (10)2 (10)
PCOS phenotype*
 Type A: menstrual disturbances, hyperandrogenism and polycystic ovaries15 (75)10 (50)
 Type B: menstrual disturbances, hyperandrogenism01 (5)
 Type D: menstrual disturbances and polycystic ovaries5 (25)9 (45)
Employment status*
 Full-time employment12 (60)11 (55)
 Part-time employment2 (10)3 (15)
 Self-employed2 (10)2 (10)
 Student1 (5)3 (15)
 Homemaker1 (5)1 (5)
 Out of work, looking for work2 (10)0
  • *Not compared at baseline.

  • CAM, complementary and alternative medicine, defined as prior use of one or more CAM treatments including Chinese herbal medicine, acupuncture, Western herbal medicine, nutritional supplements, homeopathy, aromatherapy, reiki healing, hypnotherapy, osteopathy, chiropractic or other (request to specify).

  • CHM, Chinese herbal medicine.